Burney Company’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $261K | Sell |
8,286
-52,587
| -86% | -$1.66M | 0.01% | 513 |
|
|
2025
Q1 | $1.99M | Sell |
60,873
-22,279
| -27% | -$730K | 0.07% | 212 |
|
|
2024
Q4 | $3.01M | Buy |
83,152
+71,331
| +603% | +$2.58M | 0.11% | 174 |
|
|
2024
Q3 | $369K | Sell |
11,821
-3,032
| -20% | -$94.5K | 0.01% | 481 |
|
|
2024
Q2 | $397K | Sell |
14,853
-6,366
| -30% | -$170K | 0.02% | 461 |
|
|
2024
Q1 | $724K | Sell |
21,219
-383
| -2% | -$13.1K | 0.03% | 371 |
|
|
2023
Q4 | $625K | Sell |
21,602
-50,109
| -70% | -$1.45M | 0.03% | 391 |
|
|
2023
Q3 | $1.98M | Sell |
71,711
-114,648
| -62% | -$3.16M | 0.09% | 223 |
|
|
2023
Q2 | $5.6M | Buy |
186,359
+123,487
| +196% | +$3.71M | 0.26% | 102 |
|
|
2023
Q1 | $2.28M | Buy |
62,872
+357
| +0.6% | +$12.9K | 0.11% | 206 |
|
|
2022
Q4 | $2.23M | Buy |
62,515
+36,673
| +142% | +$1.31M | 0.11% | 192 |
|
|
2022
Q3 | $875K | Sell |
25,842
-12,825
| -33% | -$434K | 0.05% | 325 |
|
|
2022
Q2 | $1.12M | Sell |
38,667
-32,492
| -46% | -$939K | 0.06% | 279 |
|
|
2022
Q1 | $2.3M | Sell |
71,159
-1,845
| -3% | -$59.6K | 0.11% | 214 |
|
|
2021
Q4 | $2.13M | Sell |
73,004
-5,911
| -7% | -$172K | 0.09% | 230 |
|
|
2021
Q3 | $2.11M | Sell |
78,915
-4,655
| -6% | -$124K | 0.1% | 216 |
|
|
2021
Q2 | $2.57M | Sell |
83,570
-894
| -1% | -$27.5K | 0.12% | 205 |
|
|
2021
Q1 | $2.21M | Sell |
84,464
-18,038
| -18% | -$472K | 0.11% | 208 |
|
|
2020
Q4 | $2.58M | Sell |
102,502
-114,211
| -53% | -$2.87M | 0.14% | 184 |
|
|
2020
Q3 | $4.52M | Buy |
216,713
+50,736
| +31% | +$1.06M | 0.28% | 110 |
|
|
2020
Q2 | $3.94M | Buy |
+165,977
| New | +$3.94M | 0.26% | 120 |
|